Hebei Changshan Biochemical Pharmaceutical Co Ltd
300255
Company Profile
Business description
Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.
Contact
North of Yinchuan Street
Zhengding New District, Hebei
Shijiazhuang050800
CHNT: +86 31189190198
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1,254
Stocks News & Analysis
stocks
Meta earnings: Strong end to 2025 as AI monetization begins to show
Investors please with latest results.
stocks
Why doesn’t the market like the earnings from this US tech giant?
Good quarter with AI demand ramping.
stocks
Our Tesla fair value increases meaningfully
Progress on Robotaxi and Optimus shows real world AI growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,164.80 | 94.40 | -1.02% |
| CAC 40 | 8,132.94 | 61.58 | 0.76% |
| DAX 40 | 24,558.14 | 248.68 | 1.02% |
| Dow JONES (US) | 48,946.66 | 124.90 | -0.25% |
| FTSE 100 | 10,216.72 | 44.96 | 0.44% |
| HKSE | 27,387.11 | 580.98 | -2.08% |
| NASDAQ | 23,639.57 | 45.55 | -0.19% |
| Nikkei 225 | 53,322.85 | 52.75 | -0.10% |
| NZX 50 Index | 13,423.18 | 74.57 | 0.56% |
| S&P 500 | 6,954.52 | 14.49 | -0.21% |
| S&P/ASX 200 | 8,869.10 | 86.00 | -0.96% |
| SSE Composite Index | 4,117.95 | 40.04 | -0.96% |